2,843 matches for your search in the start-up spotlight
rss
Thermosome is a clinical-stage drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a novel, proprietary tumor targeting approach that allows for significantly increased local drug concentrations and improved tumor ...
t2cure GmbH is a biopharmaceutical company engaged in the field of stem cell-based regenerative medicine. It develops and markets autologous bone marrow-derived progenitor cells as regenerative therapeutics for cardiovascular disease including ischemic heart disease (acute myocardial infarction ...
CYPRUMED® is a biopharmaceutical company developing a next generation platform technology for the oral delivery of polypeptides. The patent pending technology is entirely based on GRAS listed compounds and easy to formulate. In vivo studies with various polypeptide drugs in rodents, dogs and none ...
OakLabs GmbH was founded in 2011 by Dr. Martina Schad and Dr. Jim Kallarackal. OakLabs GmbH develops reliable diagnostic DNA markers for complex traits in plants. Their analysis allows the prediction of certain traits at an early stage of plant development and thus shortens the breeding of a new ...
microDimensions was founded as a spin-off of the Technical University of Munich in 2011 as a provider of integrated and efficient software solutions and services for digital pathology applications. Our mission is to shape next generation pathology by connecting human expertise with artificial ...
Personalized medicine employs accurate measurements of parameters like proteins from cells e.g. biopsies and body fluids like blood plasma or urine. This results in an increased demand for diagnostic products and new technologies for analyses. Mass spectrometry (MS) – based proteomics allows the ...
BianoScience is developing the technology of "intelligent siRNA". This enables novel therapeutic options for various diseases such as cancer and hepatitis C. Through the innovation of cell-specific gene silencing, this technology has the potential to pioneer the therapeutic use of siRNA.
Venneos GmbH is a German high-tech startup based in Stuttgart. Founded in 2014 as a spin-off from Max Planck Society, it develops and markets a silicon-chip-based Imaging System for the analysis of biological cells. Venneos' products build upon an innovative measurement approach that allows ...
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR ...
